Author

R. S. Lankalapalli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

C. K. Keerthana· 2 shared L. R. Nath· 2 shared M. Swetha· 2 shared N. H. Haritha· 2 shared R. J. Anto· 2 shared T. P. Rayginia· 2 shared A. K. T. Thulasidasan· 1 shared D. H. Wu· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. K. Keerthana

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Kaempferide induces apoptosis in cervical cancer by attenuating the HPV oncoproteins, E6 and E7

L. R. Nath, V. V. Alex, S. U. Aiswarya, T. P. Rayginia, N. H. Haritha, C. K. Keerthana, A. K. T. Thulasidasan, M. Swetha, R. S. Lankalapalli, R. J. Anto

This study shows kaempferide induces apoptosis in cervical cancer by reducing HPV oncoproteins E6 and E7 and increasing tumor suppressors.

bioRxiv · May 19, 2023 · PreprintCancer Biology

Augmented efficacy of uttroside B over sorafenib in a murine model of human hepatocellular carcinoma

M. Swetha, C. K. Keerthana, T. P. Rayginia, L. R. Nath, N. H. Haritha, K. Kalimuthu, S. Jannet, S. Pillai, K. B. Harikumar, S. Sundaram, N. P. Anto, D. H. Wu, R. S. Lankalapalli, R. Towner, N. Isakov, , R. J. Anto

This study compares the in vivo efficacy and safety of uttroside B and sorafenib in a murine model of hepatocellular carcinoma, finding Utt-B more potent and safer.

bioRxiv · Feb 1, 2022Cancer Biology